phrykt

Resmed (RMD) cash: $1.4B

Resmed held $1.4B in cash and cash equivalents on Dec 31, 2025, up 171.5% from $522M a year earlier.

From Resmed's filings with the SEC · Read the filing · RMD stock page

Resmed cash by year

$194M2021$253M2022$210M2023$522M2024$1.4B2025

#396 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$1.4B+171%
Dec 31, 2024$522M+148%
Dec 31, 2023$210M-17%
Dec 31, 2022$253M+30%
Dec 31, 2021$194M–

Cash of similar companies

Companies in the same industry as Resmed, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
Baxter International$2BDec 31, 2025
Boston Scientific$2BDec 31, 2025
Medline$1.9BDec 31, 2025
Resmed$1.4BDec 31, 2025
Dexcom$918MDec 31, 2025
Solventum$878MDec 31, 2025
West Pharmaceutical Services$791MDec 31, 2025

Questions and answers

What is Resmed's cash?

Resmed held $1.4B in cash and cash equivalents on Dec 31, 2025, up 171.5% from $522M a year earlier.

Numbers as reported in Resmed's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology